LifeStance Health Group (LFST) Osake Kurssi
LifeStance Health Group Kurssi
Liikevaihto on kasvanut 37,3 % vuodessa viimeisten 6 vuoden aikana 1,42 Mrd. USD:een. LifeStance Health Groupn nettomarginaali on nyt 0,7 %, noussut −46,0 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 13,00 USD, eli yli nykyhintaa 5,4 %. 18 analyytikosta 14 suosittaa ostoa — kokonaiskonsensus on Osta.
LifeStance Health Group osakekurssi
LifeStance Health Group liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset LifeStance Health Group -osakkeesta
Lifestance Health Group Inc is a leading healthcare organization specializing in providing comprehensive mental health services. Their business model encompasses the integration of psychiatrists, clinical psychologists, therapists, and psychiatric nurse practitioners to offer personalized and evidence-based treatment to individuals of all ages. By combining a multidisciplinary approach with innovative technologies, Lifestance Health Group Inc aims to deliver high-quality and accessible mental healthcare across their network of clinics. With a focus on patient-centric care and a commitment to improving mental wellness, Lifestance Health Group Inc has become a trusted provider in the industry, striving to make a positive impact on individuals' lives.
Lifestance Health Group Inc is primarily active in the healthcare industry.
The main competitors of Lifestance Health Group Inc in the market include companies such as Acadia Healthcare Company Inc, Universal Health Services Inc, and HCA Healthcare Inc.
Lifestance Health Group Inc is a leading provider of mental health services in the United States. Founded in 2005, the company has a rich history of offering comprehensive and personalized care to individuals struggling with mental health conditions. Lifestance Health Group Inc has established itself as a trusted name in the industry by combining evidence-based practices with a patient-centered approach. With a team of experienced and compassionate clinicians, the company offers a wide range of services, including therapy, medication management, and telepsychiatry. Lifestance Health Group Inc continues to grow and expand its reach to help improve the lives of individuals facing mental health challenges.
Lifestance Health Group Inc has achieved several significant milestones in its journey. The company has successfully expanded its network, establishing a strong presence across multiple states in the United States. Lifestance Health Group Inc has also developed a reputation for excellence in its specialized behavioral health services, offering comprehensive care to patients. The company has consistently grown its patient base, delivering high-quality care and demonstrating exceptional clinical outcomes. Lifestance Health Group Inc has continually focused on innovation, leveraging technology to improve patient experience and streamline operations. Overall, Lifestance Health Group Inc has exhibited impressive growth and success in the behavioral health industry, solidifying its position as a leading provider.
Lifestance Health Group Inc is primarily present in the United States.
Lifestance Health Group Inc represents a strong commitment to providing high-quality mental health care services. The company prides itself on its patient-centered approach, putting individuals at the forefront of their treatment plans. Lifestance Health Group Inc believes in promoting the overall well-being of their patients by offering personalized and evidence-based treatment options. The company's corporate philosophy revolves around creating a supportive and compassionate environment, fostering growth and resilience for their patients. By emphasizing collaboration and innovation, Lifestance Health Group Inc ensures that individuals receive comprehensive care that addresses their unique needs.
Analyytikot asettavat tällä hetkellä LifeStance Health Group-osakkeelle keskimääräisen tavoitehinnan 12,86 USD (mediaani: 13,00 USD), mikä merkitsee +4,3 % viimeisimpään hintaan verrattuna. Konsensus perustuu 18 analyytikkoarvioon.
18 analyytikkoa arvioi tällä hetkellä LifeStance Health Group-osaketta: 14 suosittaa ostoa, 4 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat LifeStance Health Group-yhtiöltä 1,71 Mrd. USD liikevaihtoa ja 0,16 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla LifeStance Health Group-osake noteerataan hintaan 11,01 EUR (12,34 USD).
LifeStance Health Group-osake (LFST) on listattuna 1 pörssissä, muun muassa: NASDAQ (LFST).
Lifestance Health Group Inc is a leading provider of behavioral health services in the United States. The company was founded to make mental health services more accessible to a wider audience by developing innovative solutions tailored to the individual needs and requirements of each patient. Lifestance Health Group offers holistic mental health services provided by experienced and qualified professionals. These services include psychological counseling, psychotherapy, psychiatry, neuropsychology, and clinical social work. The company also offers telehealth services that allow customers to virtually connect with their healthcare providers, as well as specialized programs for children, adolescents, and families. The company operates in three main segments: Clinic Segment, Telehealth Services, and Specialized Programs. In summary, Lifestance Health Group offers a comprehensive portfolio of mental health services tailored to the specific needs and requirements of each patient. The company is committed to developing innovative solutions to facilitate access to mental health services and improve people's quality of life.
odotettu liikevaihto LifeStance Health Group on 1,71 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto LifeStance Health Group on 62,79 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
LifeStance Health Group:n hinta-voitto-suhde (P/E) on tällä hetkellä 77,23. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan LifeStance Health Group-osakkeen arvostusta.
LifeStance Health Group:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,84. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii LifeStance Health Group-osakkeen arvostuskennuslukuna.
LifeStance Health Group:n Eulpool-laatuscore on 4/10.
LifeStance Health Group:n ISIN on US53228F1012. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
LifeStance Health Group:n ticker on LFST. Tämä pörssinoteeraus käytetään LifeStance Health Group-osakkeiden kauppaan pörssissä.
LifeStance Health Group osake
LifeStance Health Group vertaisryhmä
LifeStance Health Group Ticker
LifeStance Health Group FIGI
Kaikki tunnusluvut ja syvällinen analyysi LifeStance Health Group:sta
Meidän osakeanalyysimme LifeStance Health Group-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut LifeStance Health Group:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: